Scinai Immunotherapeutics Ltd (SCNI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.05M
Last updated: Nov 17, 2026 at 10:54 AM ET
Scinai Immunotherapeutics Ltd (SCNI) Competitors
The companies most similar to Scinai Immunotherapeutics are Scisparc (SPRC), HCW Biologics (HCWB) and Silexion Therapeutics (SLXN). By market cap, Scinai Immunotherapeutics ranks 10th of the 13 companies on this page; Imunon (IMNN) is the largest at $4.08M.
Peer Comparison
SCNI's revenue growth of 572.0% is above the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Scinai Immunotherapeutics (SCNI) | $1.05M | N/A | N/A | -80.1% | N/A | 572.0% | 0.00% |
| Scisparc Ltd (SPRC) | $869840 | N/A | N/A | 0.0% | N/A | -38.4% | 0.00% |
| HCW Biologics Inc (HCWB) | $1.73M | N/A | 0.2x | -83.1% | -51.6% | 1970.0% | 0.00% |
| Silexion Therapeutics Corp (SLXN) | $1.29M | N/A | 5.9x | 0.0% | N/A | 0.0% | 0.00% |
| Calidi Biotherapeutics Inc. (CLDI) | $2.29M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Kairos Pharma, Ltd. (KAPA) | $1.54M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Enlivex Therapeutics Ltd (ENLV) | $1.82M | N/A | N/A | 0.0% | -0.3% | 0.0% | 0.00% |
| Onconetix Inc (ONCO) | $2.15M | N/A | 1.0x | 0.0% | N/A | -83.9% | 0.00% |
| Matinas BioPharma Holdings Inc (MTNB) | $881570 | 0.9x | N/A | 0.0% | -187.9% | -100.0% | 0.00% |
| GeoVax Labs Inc (GOVX) | $928290 | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Ernexa Therapeutics Inc. (ERNA) | $2.84M | N/A | N/A | 0.0% | N/A | -94.1% | 0.00% |
| Imunon Inc (IMNN) | $4.08M | N/A | N/A | 0.0% | -131.5% | 0.0% | 0.00% |
| Revelation Biosciences Inc (REVB) | $2.43M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $1.78M | 0.9x | 1.0x | 0.0% | -91.6% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Scinai Immunotherapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Scisparc Ltd (SPRC) | SciSparc Ltd., a specialized clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. | |
| HCW Biologics Inc (HCWB) | HCW Biologics Inc is a forward-thinking biotechnology company focused on pioneering immunotherapies and vaccine technologies to tackle pressing health issues... | HCWB competitors |
| Silexion Therapeutics Corp (SLXN) | Biomotion Sciences (SLXN) is a forward-thinking biotechnology firm specializing in regenerative medicine... | SLXN competitors |
| Calidi Biotherapeutics Inc. (CLDI) | Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. | CLDI competitors |
| Kairos Pharma, Ltd. (KAPA) | Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients. | KAPA competitors |
| Enlivex Therapeutics Ltd (ENLV) | Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel. | ENLV competitors |
| Onconetix Inc (ONCO) | Onconetix Inc. is a cutting-edge biotechnology firm committed to revolutionizing cancer care with its innovative diagnostic and therapeutic solutions. | ONCO competitors |
| Matinas BioPharma Holdings Inc (MTNB) | Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery and development of several candidate products. | MTNB competitors |
| GeoVax Labs Inc (GOVX) | GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified... | GOVX competitors |
| Ernexa Therapeutics Inc. (ERNA) | Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. | ERNA competitors |
| Imunon Inc (IMNN) | Imunon Inc. is a clinical-stage biotechnology company at the forefront of developing innovative immune-mediated therapies targeting cancer and infectious... | IMNN competitors |
| Revelation Biosciences Inc (REVB) | Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics... | REVB competitors |
Frequently Asked Questions About SCNI
Who are Scinai Immunotherapeutics' main competitors?
The companies most similar to Scinai Immunotherapeutics include Scisparc (SPRC), HCW Biologics (HCWB), Silexion Therapeutics (SLXN), Calidi Biotherapeutics (CLDI) and Kairos Pharma (KAPA), listed from the closest match.
Who is Scinai Immunotherapeutics' biggest competitor?
Imunon (IMNN) is the largest of the similar companies at $4.08M; Scisparc (SPRC) is the closest match by business profile, size, sector and industry.
How does SCNI stock compare with its competitors?
SCNI's net margin is -80.1% against a peer median of 0.0%.
Which of Scinai Immunotherapeutics' competitors pays a higher dividend?
Scinai Immunotherapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Scinai Immunotherapeutics bigger than its competitors?
No. Scinai Immunotherapeutics is 10th by market cap among the 13 companies on this page; the largest is Imunon (IMNN) at $4.08M.
SCNI pages: Overview, Earnings, Financials, Competitors